![]() | Up a level |
Journal Article
Bobylev, Ilja, Peters, Dominik, Vyas, Maulik ORCID: 0000-0003-2996-4682, Barham, Mohammed, Klein, Ines, von Strandmann, Elke Pogge, Neiss, Wolfram F. and Lehmann, Helmar C.
(2017).
Kinesin-5 Blocker Monastrol Protects Against Bortezomib-Induced Peripheral Neurotoxicity.
Neurotox. Res., 32 (4).
S. 555 - 563.
NEW YORK:
SPRINGER.
ISSN 1476-3524
Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael, von Strandmann, Elke Pogge and Koehl, Ulrike (2018). Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset (vol 8, 1100, 2017). Front. Immunol., 9. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-3224
Kloess, Stephan, da Silva, Alessa Ede Valverde, Oberschmidt, Olaf, Gardlowski, Tanja, Matthies, Nadine, Vyas, Maulik, Arseniev, Lubomir, Heuser, Michael ORCID: 0000-0001-5318-9044, von Strandmann, Elke Pogge and Koehl, Ulrike
(2017).
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.
Front. Immunol., 8.
LAUSANNE:
FRONTIERS MEDIA SA.
ISSN 1664-3224
Vyas, Maulik ORCID: 0000-0003-2996-4682, Schneider, Ann-Charlott, Shatnyeva, Olga, Reiners, Katrin S., Tawadros, Samir, Kloess, Stephan, Koehl, Ulrike, Hallek, Michael, Hansen, Hinrich P. and von Strandmann, Elke Pogge
(2016).
Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.
OncoImmunology, 5 (9).
PHILADELPHIA:
TAYLOR & FRANCIS INC.
ISSN 2162-402X
Thesis
Vyas, Maulik
(2016).
Development of novel trispecific immunoligands (triplebodies) to retarget natural killer cells against chronic lymphocytic leukemia.
PhD thesis, Universität zu Köln.